Citizens Lifts Benitec Biopharma Inc. (BNTC) Price Target on Topline Results for Oculopharyngeal Muscular Dystrophy Treatment
Benitec Biopharma Inc. (NASDAQ:BNTC) is one of the best breakout stocks to invest in.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Persistent Asset Partners Xin Huang | 12,493 | $167,156 | -32% | 0.05% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.44 | 11,587 | $155,729.28 | 1,848,156 | 2025-12-29 | Filing | |
| $13.44 | 65,800 | $884,352.00 | 9,700,195 | 2025-12-29 | Filing | |
| $13.10 | 2,516 | $32,959.60 | 1,836,569 | 2025-12-26 | Filing | |
| $13.10 | 14,320 | $187,592.00 | 9,634,395 | 2025-12-26 | Filing | |
| $12.85 | 7,400 | $95,090.00 | 1,834,053 | 2025-12-23 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,407,138 | $18,827,507 | 0% | |
| 2. | 1,005,557 | $13,454,353 | 0.19% | |
| 3. | 377,973 | $5,057,279 | 0% | |
| 4. | 115,092 | $1,539,929 | 0% | |
| 5. | 60,061 | $803,616 | 0% |